LONDON BROKER RATINGS: Berenberg says 'buy' Elixirr International
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 15,118.00p on 17-04-2026 at 18:50:06 |
|---|---|
| Change | 256.00p 1.72% |
| Buy | 15,102.00p |
| Sell | 15,100.00p |
| Last Trade: | Unknown 6.00 at 15,182.01039p |
| Day's Volume: | 2,867,650 |
| Last Close: | 15,118.00p |
| Open: | 14,736.00p |
| ISIN: | GB0009895292 |
| Day's Range | 14,736.00p - 15,118.00p |
| 52wk Range: | 9,651.00p - 15,730.00p |
| Market Capitalisation: | £234.45b |
| VWAP: | 14,873.97098p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 6 | 15,182.01039p | SI Trade Currency Conversion |
19:01:49 - 17-Apr-26 |
| Unknown* | 0 | 15,182.75022p | SI Trade Currency Conversion |
19:00:20 - 17-Apr-26 |
| Unknown* | 0 | 15,184.9697p | SI Trade Currency Conversion |
18:59:05 - 17-Apr-26 |
| Unknown* | 0 | 15,176.09176p | SI Trade Currency Conversion |
18:59:05 - 17-Apr-26 |
| Unknown* | 0 | 15,174.61211p | SI Trade Currency Conversion |
18:57:17 - 17-Apr-26 |
| Unknown* | 0 | 15,157.59606p | Currency Conversion OTC Trade |
18:50:12 - 17-Apr-26 |
| Unknown* | 2 | 15,158.32849p | Currency Conversion Negotiated Trade OTC Trade |
18:43:42 - 17-Apr-26 |
| Unknown* | 0 | 15,163.51469p | SI Trade Currency Conversion |
18:37:41 - 17-Apr-26 |
| Unknown* | 0 | 15,167.21383p | SI Trade Currency Conversion |
18:19:40 - 17-Apr-26 |
| Unknown* | 0 | 15,153.89692p | Currency Conversion OTC Trade |
18:12:34 - 17-Apr-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 5:15 pm | RNS | Result of AGM |
| 2nd Apr 2026 7:00 am | RNS | Imfinzi+Imjudo improves PFS in early liver cancer |
| 1st Apr 2026 3:00 pm | RNS | Total Voting Rights and Admission of Shares |
| 31st Mar 2026 7:00 am | RNS | Efzimfotase alfa Ph3 program show positive results |
| 27th Mar 2026 7:00 am | RNS | Tozorakimab met OBERON/TITANIA primary endpoints |
| 20th Mar 2026 11:00 am | RNS | Notification of Admission of Shares |
| 16th Mar 2026 7:00 am | RNS | Imfinzi approved in EU for early gastric cancer |
| 16th Mar 2026 7:00 am | RNS | Imfinzi approved in EU for early gastric cancer |
| 10th Mar 2026 11:00 am | RNS | Notice of AGM |
| 10th Mar 2026 11:00 am | RNS | Notice of AGM |